文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

创伤性脑损伤合并失血性休克患者使用全血与死亡率降低无关

Whole blood use in patients with traumatic brain injury and hemorrhagic shock is not associated with decreased mortality.
PubMed 文献 · J Trauma Acute Care Surg · 2025-06-30
一句话结论在创伤性脑损伤合并失血性休克患者中,全血联合成分输血较单纯成分输血未降低院内死亡率(OR 1.06,95%CI 0.65-1.75)。

这项前瞻性、多中心、观察性数据库研究纳入535例创伤性脑损伤合并失血性休克患者,其中135例仅接受成分输血,400例接受全血联合成分输血。两组中位损伤严重度评分、年龄、合并症、严重颅脑损伤比例及入院24小时内总成分输血量无差异;全血组男性、休克状态及钝性创伤比例更高。多因素logistic回归控制休克指数、损伤严重度评分、年龄、性别、合并症、严重颅脑损伤及损伤机制后,全血使用与较低死亡率无独立关联(OR 1.06,95%CI 0.65-1.75,P=0.809)。作者结论认为,在创伤性脑损伤合并失血性休克患者中,全血联合成分输血未带来院内死亡率获益,需进一步研究最佳复苏策略。

要点

  • 在创伤性脑损伤合并失血性休克患者中,全血联合成分输血较单纯成分输血未降低院内死亡率(OR 1.06,95%CI 0.65-1.75,P=0.809)。
  • 全血组与单纯成分输血组入院24小时内总成分输血量无差异(P>0.05)。
  • 全血组男性、休克状态及钝性创伤比例更高(P<0.05),多因素回归已控制休克指数、损伤严重度评分、年龄、性别、合并症、严重颅脑损伤及损伤机制。
  • 该研究为前瞻性、多中心、观察性数据库研究,证据等级为治疗/临床管理 Level III。

适用人群与场景

  • 创伤性脑损伤合并失血性休克的创伤患者,来自前瞻性、多中心、观察性数据库。

研究设计与关键结果

  • 研究类型:前瞻性、多中心、观察性数据库研究;样本量535例,其中单纯成分输血组135例,全血联合成分输血组400例。
  • 两组中位损伤严重度评分、年龄、合并症存在比例、严重颅脑损伤比例及入院24小时内总成分输血量无差异(P>0.05)。
  • 全血组男性、休克状态及钝性创伤比例更高(P<0.05)。
  • 多因素logistic回归控制休克指数、损伤严重度评分、年龄、性别、合并症、严重颅脑损伤及损伤机制后,全血使用与较低死亡率无独立关联(OR 1.06,95%CI 0.65-1.75,P=0.809)。
  • 作者结论:在创伤性脑损伤合并失血性休克患者中,全血联合成分输血未带来院内死亡率获益,需进一步研究最佳复苏策略。

证据类型、等级与局限

  • 证据类型:前瞻性、多中心、观察性数据库研究;证据等级:治疗/临床管理 Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在创伤性脑损伤合并失血性休克患者中,全血联合成分输血未显示较单纯成分输血降低院内死亡率(OR 1.06,95%CI 0.65-1.75)。
  • 作者认为,需进一步研究此类患者的最佳复苏策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) is a leading cause of trauma mortality worldwide. Whole blood (WB) is associated with decreased mortality compared with blood component therapy (BCT) alone in trauma patients with hemorrhagic shock (HS). The ideal resuscitation approach in patients with both TBI and HS remains unclear. We hypothesize that resuscitation with WB in trauma patients with TBI and HS improves mortality.

METHODS: Using a prospective, multicenter, observational database, we examined a subset of patients with TBI and HS. We compared patients receiving BCT only for resuscitation with those receiving WB with BCT. We used χ 2 and Kruskal-Wallis tests to compare categorical and continuous variables by the use of WB. We conducted a multivariable logistic regression to examine the association between WB and mortality controlling for shock index, Injury Severity Score, age, sex, comorbid conditions, serious head injury, and mechanism of injury.

RESULTS: A total of 535 patients were included. One hundred thirty-five patients received BCT, and 400 patients received WB with BCT. There were no differences in the median Injury Severity Score, age, presence of comorbid conditions, proportion of serious head injury, or total component transfusions in the first 24 hours of admission ( p > 0.05). More patients in the WB group were male, in shock, and experienced blunt trauma ( p < 0.05). On multivariable logistic regression, WB use was not independently associated with lower mortality (odds ratio, 1.06; [95% confidence interval, 0.65-1.75]; p=0.809).

CONCLUSION: We identified no in-hospital mortality benefit of WB transfusion in addition to BCT in trauma patients with TBI and HS. Further research is needed into optimal resuscitation strategies for these patients.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Eng NL, Shen C, Pradhan S, et al. Whole blood use in patients with traumatic brain injury and hemorrhagic shock is not associated with decreased mortality. J Trauma Acute Care Surg. 2025. PMID: 40587336. doi:10.1097/TA.0000000000004730

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。